Search

everythinglearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Oxidative stress contributes to hair graying and loss as we age.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The woman has a type of scarring hair loss with red bumps around hair follicles.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Red dots on the upper chest may be an early sign of certain types of hair loss.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.